| Withdrawn | Absolute Bioavailability Study With Bexagliflozin Type 2 Diabetes Mellitus | Phase 1 | 2018-08-01 |
| Completed | Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment Type2 Diabetes Mellitus | Phase 1 | 2018-07-26 |
| Completed | Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Sub Type2 Diabetes Mellitus | Phase 3 | 2017-11-28 |
| Completed | An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hype Essential Hypertension | Phase 2 / Phase 3 | 2017-10-18 |
| Completed | Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2017-10-12 |
| Completed | Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2017-09-27 |
| Completed | Bexagliflozin Drug/Drug Interaction Study With Digoxin Type2 Diabetes Mellitus | Phase 1 | 2017-07-24 |
| Completed | Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection Type2 Diabetes Mellitus | Phase 1 | 2017-05-24 |
| Completed | Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin Type2 Diabetes Mellitus | Phase 1 | 2016-11-01 |
| Completed | Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment Type 2 Diabetes Mellitus | Phase 3 | 2016-09-23 |
| Completed | Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2016-08-15 |
| Completed | Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2016-06-20 |
| Completed | Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2016-03-01 |
| Completed | Bexagliflozin Efficacy and Safety Trial Type 2 Diabetes Mellitus | Phase 3 | 2015-10-01 |
| Completed | A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Me Diabetes Mellitus, Type 2 | Phase 2 | 2015-05-12 |
| Completed | Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus Diabetes Mellitus | Phase 2 | 2011-12-01 |
| Completed | Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects Obesity | Phase 1 | 2010-05-01 |
| Completed | Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Diabetes Mellitus Type 2 | Phase 2 | 2009-12-01 |
| Completed | Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes Diabetes Mellitus Type 2 | Phase 1 | 2009-06-01 |
| Completed | Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunte Safety and Tolerability of EGT0001474 in Healthy Volunteers | Phase 1 | 2009-02-01 |
| Completed | Efficacy and Safety of THR-4109 in Obese Subjects Obesity | Phase 2 | 2007-08-01 |